ARTICLE SUMMARY:
Sensome’s dream of enabling real-time analysis of clot features during the treatment of acute ischemic stroke has become closer to a reality, after a recent demonstration of human feasibility, a collaboration with an important manufacturing partner, and the publication of clinical literature supporting the procedural relevance of the information it provides.
Sensome (Massy, France), which was spun out of the French National Center for Scientific Research (CNRS) and École polytechnique in 2014 to develop a sensor on a guidewire for measuring clot features, has recently made great strides at a time when the neurology specialty it is targeting recognizes the problem that it solves—the impact of clot features on the efficiency of thrombectomy procedures in patients with acute ischemic stroke.
